Evidence map›Paper›PMID 19615742›Full record

ArticlePlacenta2009

Effect of DMPS and DMSA on the placental and fetal disposition of methylmercury.

C C Bridges, L Joshee, R K Zalups

Abstract read
In one paragraph

Article in Placenta, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Disposition of methylmercury over time in a 75% nephrectomized rat model.Journal of toxicology and environmental health. Part A · 2018
    Article
  11. Chronic Kidney Disease and Exposure to Nephrotoxic Metals.International journal of molecular sciences · 2017
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Is Challenge Testing Valid for Assessing Body Metal Burden?Integrative medicine (Encinitas, Calif.) · 2015
    Article
  17. Article
  18. Oxidative stress in MeHg-induced neurotoxicity.Toxicology and applied pharmacology · 2011
    Review
  19. Transport of inorganic mercury and methylmercury in target tissues and organs.Journal of toxicology and environmental health. Part B, Critical reviews · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

C C BridgesDivision of Basic Medical Sciences, Mercer University School of Medicine, 1550 College Street, Macon, GA 31207, USA. bridges_cc@mercer.edu
L Joshee
R K Zalups
Mercer University · US

Funding

Role of Multidrug Resistance Proteins 2 and/or 4, and DMPS and DMSA in the RenalR03ES015511 · NIEHS · MERCER UNIVERSITY MACON · PI BRIDGES, CHRISTY C · 2007 to 2008
$145k
NIEHS NIH HHS R03 ES015511
6 · The paper itself

Abstract

Methylmercury (CH3Hg+) is a serious environmental toxicant. Exposure to this metal during pregnancy can cause serious neurological and developmental defects in a developing fetus. Surprisingly, little is known about the mechanisms by which mercuric ions are transported across the placenta. Although it has been shown that 2,3-dimercaptopropane-1-sulfonate (DMPS) and 2,3-dimercaptosuccinic acid (DMSA) are capable of extracting mercuric ions from various organs and cells, there is no evidence that they are able to extract mercury from placental or fetal tissues following maternal exposure to CH3Hg+. Therefore, the purpose of the current study was to evaluate the ability of DMPS and DMSA to extract mercuric ions from placental and fetal tissues following maternal exposure to CH3Hg+. Pregnant Wistar rats were exposed to CH3HgCl, containing [203Hg], on day 11 or day 17 of pregnancy and treated 24 h later with saline, DMPS or DMSA. Maternal organs, fetuses, and placentas were harvested 48 h after exposure to CH3HgCl. The disposition of mercuric ions in maternal organs and tissues was similar to that reported previously by our laboratory. The disposition of mercuric ions in placentas and fetuses appeared to be dependent upon the gestational age of the fetus. The fetal and placental burden of mercury increased as fetal age increased and was reduced by DMPS and DMSA, with DMPS being more effective. The disposition of mercury was examined in liver, total renal mass, and brain of fetuses harvested on gestational day 19. On a per gram tissue basis, the greatest amount of mercury was detected in the total renal mass of the fetus, followed by brain and liver. DMPS and DMSA reduced the burden of mercury in liver and brain while only DMPS was effective in the total renal mass. The results of the current study are the first to show that DMPS and DMSA are capable of extracting mercuric ions, not only from maternal tissues, but also from placental and fetal tissues following maternal exposure to CH3Hg+.

Indexed as

Maternal ExposureAnimalsBrainBrain ChemistryChelating AgentsFemaleFetal WeightFetusGestational AgeHazardous SubstancesInjections, IntravenousKidneyLiverMaternal-Fetal ExchangeMercuryMethylmercury CompoundsChelating AgentsHazardous SubstancesMercurymethylmercuric chlorideMethylmercury CompoundsSuccimerUnithiol

Identifiers

PMID19615742
PMCPMC2739879
OpenAlexW2089990836

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.